BioTech/Drugs - N/A, N/A, ES
We make antibodies that neutralize Dual SMAD Inhibiting Proteins (DSIPs). These secreted proteins induce the indefinite replication of certain cells in the body. To find our antibody drug prototypes, we are building Spain´s first naive antibody library spiked with artificial intelligence. We then use our proprietary screening technology, called the Transferrable SMAD Sensor System (TSSS), to find exactly which sequences have instructions to make a functional antibody that neutralizes one DSIP. We then engineer our antibody medicines to make sure they are the best drugs possible for a particular disease. Each of our antibody medicines may be used to treat a wide variety of clinical needs, such as breast cancer and selected rare diseases.
Outlook
NSOne
Typekit
Shutterstock